Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locus

American Journal of Medical Genetics, Part A

Volumn 161, Issue 3, 2013, Pages 605-610

  Van Mater, David ^a   Knelson, Erik H ^a   Kaiser Rogers, Kathleen A ^b   Armstrong, Michael B ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

MYCN duplication; Neuroblastoma; Partial trisomy 2p

Indexed keywords

CATECHOLAMINE; CD45 ANTIGEN; CD99 ANTIGEN; CHROMOGRANIN; CISPLATIN; CYCLOPHOSPHAMIDE; DESMIN; DOXORUBICIN; ETOPOSIDE; MYOGENIN; SYNAPTOPHYSIN; TOPOTECAN; VINCRISTINE;

ABDOMINAL MASS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CASE REPORT; CATECHOLAMINE URINE LEVEL; CONSTIPATION; CRANIOFACIAL SYNOSTOSIS; CYTAPHERESIS; CYTOGENETICS; DEVELOPMENTAL DELAY; DEVELOPMENTAL DISORDER; ECHOGRAPHY; GENE DELETION; GENE DUPLICATION; GENE IDENTIFICATION; GENE LOCUS; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTELORISM; IMMUNOHISTOCHEMISTRY; INFANT; IRON DEFICIENCY ANEMIA; MALE; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; ONCOGENE C MYB; PARTIAL TRISOMY 2P; PARTIAL TRISOMY 9; POLYDACTYLY; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR BIOPSY; VOMITING;

ABDOMINAL NEOPLASMS; ABNORMALITIES, MULTIPLE; CHROMOSOME DUPLICATION; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 3; GENE AMPLIFICATION; GENETIC LOCI; HUMANS; INFANT; MALE; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; THORACIC NEOPLASMS;

EID: 84874219954     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35766     Document Type: Article

References (29)

1. Al-Saffar M, Lemyre E, Koenekoop R, Duncan AM, Der Kaloustian VM. 2000. Phenotype of a patient with pure partial trisomy 2p(p23→pter). Am J Med Genet 94: 428-432.
2. Biesecker LG, Aase JM, Clericuzio C, Gurrieri F, Temple IK, Toriello H. 2009. Elements of morphology: Standard terminology for the hands and feet. Am J Med Genet Part A 149A: 93-127.
3. Briegel KJ, Baldwin HS, Epstein JA, Joyner AL. 2005. Congenital heart disease reminiscent of partial trisomy 2p syndrome in mice transgenic for the transcription factor LBH. Development 132: 3305-3316.
4. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. 1984. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121-1124.
5. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, Haase G, Hartmann O, Hayes FA, Helson L, Kemshead J, Lampert F, Ninane J, Ohkawa H, Philip T, Pinkerton CR, Pritchard J, Sawada T, Siegel S, Smith EI, Tsuchida Y, Voute PA. 1988. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6: 1874-1881.
6. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA. 1993. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477.
7. Corvi R, Savelyeva L, Schwab M. 1995. Duplication of N-myc at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res 55: 3471-3474.
8. De Preter K, Speleman F, Combaret V, Lunec J, Laureys G, Eussen BH, Francotte N, Board J, Pearson AD, De Paepe A, Van Roy N, Vandesompele J. 2002. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol 15: 159-166.
9. Dowa Y, Yamamoto T, Abe Y, Kobayashi M, Hoshino R, Tanaka K, Aida N, Take H, Kato K, Tanaka Y, Ariyama J, Harada N, Matsumoto N, Kurosawa K. 2006. Congenital neuroblastoma in a patient with partial trisomy of 2p. J Pediatr Hematol Oncol 28: 379-382.
10. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BKe (eds). 2011. SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute. http://SEER.Cancer.Gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
11. Jacobs JF, van Bokhoven H, van Leeuwen FN, Hulsbergen-van de Kaa CA, de Vries IJ, Adema GJ, Hoogerbrugge PM, de Brouwer AP. 2009. Regulation of MYCN expression in human neuroblastoma cells. BMC Cancer 9: 239.
12. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome browser at UCSC. Genome Res 12: 996-1006.
13. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
14. Lurie IW, Ilyina HG, Gurevich DB, Rumyantseva NV, Naumchik IV, Castellan C, Hoeller A, Schinzel A. 1995. Trisomy 2p: Analysis of unusual phenotypic findings. Am J Med Genet 55: 229-236.
15. Mosse YP, Laudenslager M, Khazi D, Carlisle AJ, Winter CL, Rappaport E, Maris JM. 2004. Germline PHOX2B mutation in hereditary neuroblastoma. Am J Hum Genet 75: 727-730.
16. Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, Laureys G, Speleman F, Kim C, Hou C, Hakonarson H, Torkamani A, Schork NJ, Brodeur GM, Tonini GP, Rappaport E, Devoto M, Maris JM. 2008. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455: 930-935.
17. Nagano H, Kano Y, Kobuchi S, Kajitani T. 1980. A case of partial 2p trisomy with neuroblastoma. Jinrui Idengaku Zasshi 25: 39-45.
18. Park JR, Eggert A, Caron H. 2010. Neuroblastoma: Biology, prognosis, and treatment. Hematol Oncol Clin North Am 24: 65-86.
19. Patel JS, Pearson J, Willatt L, Andrews T, Beach R, Green A. 1997. Germline duplication of chromosome 2p and neuroblastoma. J Med Genet 34: 949-951.
20. Say B, Carpenter NJ, Giacoia G, Jegathesan S. 1980. Agenesis of the lung associated with a chromosome abnormality (46, xx, 2p+). J Med Genet 17: 477-478.
21. Schinzel A. 2001. Catalogue of unbalanced chromosome aberrations in man. Berlin, New York: Walter de Gruyter. xvii, 966 pp.
22. Schwab M. 2004. MYCN in neuronal tumours. Cancer Lett 204: 179-187.
23. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J. 1983. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305: 245-248.
24. Scott D, Elsden J, Pearson A, Lunec J. 2003. Genes co-amplified with MYCN in neuroblastoma: Silent passengers or co-determinants of phenotype? Cancer Lett 197: 81-86.
25. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. 1985. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111-1116.
26. Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, O'Meara A, Ryan E, Catchpoole D, Breatnach F. 2004. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma. Cytogenet Genome Res 106: 49-54.
27. Trochet D, Bourdeaut F, Janoueix-Lerosey I, Deville A, de Pontual L, Schleiermacher G, Coze C, Philip N, Frebourg T, Munnich A, Lyonnet S, Delattre O, Amiel J. 2004. Germline mutations of the paired-like homeobox 2b (PHOX2B) gene in neuroblastoma. Am J Hum Genet 74: 761-764.
28. Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM. 2010. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363: 1324-1334.
29. Yuksel A, Seven M, Karaman B, Yilmaz S, Deviren A, Hacihanefioglu S, Basaran S. 2002. Neuroblastoma in a dysmorphic girl with a partial duplication of 2p caused by an unbalanced translocation. Clin Dysmorphol 11: 39-42.